Paint Medical Patents Green Or Improve Efficacy 08/03/2017 by Intellectual Property Watch 1 Comment Danny Friedmann writes: When the holder of a medical patent finds herself on the patent cliff, staring into the abyss of a patentless and incomeless future, she will become very ingenious in applying for new uses, new pathways of delivery and new doses of the known substance. Painting a new layer of green over the patent that must give the impression of a new invention. It is the duty of the legislator to limit this kind of behavior if it stifles access to generic medicines. How can the interests of patent holders and patients be reconciled?
EPO Sees Highest Patent Filings Ever; Chinese Applications Still Rising 07/03/2017 by Intellectual Property Watch 2 Comments The European Patent Office published its 2016 annual report today, showing an “unprecedented level of patent filings,” and underlining the growing number of patent applications from China. The top technical fields for applications included medical technology, digital communication, and pharmaceuticals.
A Review Of ‘Standard Essential Patents Within Global Networks – An Emerging Economies Perspective’ By Dieter Ernst 06/03/2017 by Guest contributor for Intellectual Property Watch Leave a Comment By Roya Ghafele, OxFirst – Dieter Ernst’s study is one of the few, if not the only one, to thoroughly examine the role, function and effects of Standard Essential Patents from a developing country’s perspective. As such, the study is a refreshing read, given that the discourse on Standard Essential Patents and the FRAND (fair reasonable and non-discriminatory) regime is pretty much driven from a developed country’s point of view.
Patent Data – The Modern Investor’s Crystal Ball 06/03/2017 by Intellectual Property Watch 2 Comments Sirena Rubinoff writes: What if there was a crystal ball that could tell you where and when to invest your money? It sounds like science fiction, but engineers at MIT have actually developed a formula that can predict future events in tech development. The formula is based on a combination of big data from patent applications and smart analytics which, when put together, can estimate how fast a technology is advancing.
New Gene-Editing Technology Whets Appetites In Health, Food Industry, Fuels Patent Fights 16/02/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment A new discovery allowing easier and swifter genome editing, considered by some as a major game changer in the field of biology, is opening doors to new technological wonders in many areas, such as medicines and agriculture. Yesterday, the United States Patent and Trademark Office issued a ruling on a case where two US university laboratories both claimed the invention of a genome editing technique. The USPTO decided that the two universities had made distinct discoveries. In Europe, patents from both universities on the technology are also challenged at the European Patent Office.
Hepatitis C Patent Challenges In India, Argentina To Allow Generic Production 14/02/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment Resistance to high prices for hepatitis C drugs is ongoing as five new challenges against patents have been filed in India and Argentina, according to sources. Those challenges aim at allowing the production and distribution of affordable generic versions of new hepatitis C medicines (direct-acting antivirals).
Patentability Of Some Biotech Uncertain In Europe As Examination, Opposition Suspended 09/02/2017 by Catherine Saez, Intellectual Property Watch 1 Comment The patentability of plants or animals that have been obtained by natural occurrence such as selection and crossing has been a recurrent issue discussed at the European Patent Office (EPO). A recent notice from the European Commission challenged a ruling by the EPO Enlarged Board of Appeal on such patents, prompting yet more discussions in the organisation. In the meantime, all examination and opposition on such patents have been halted at the EPO. Industry is concerned that the EPO ruling might be questioned, and warns of effects on innovation, harm to applicants. Civil society is concerned about a non-transparent process.
The New Caribbean Patent Convention And Caricom Stasis 06/02/2017 by Intellectual Property Watch 3 Comments Abiola Inniss writes: The creation of the Caribbean Patent Convention under the auspices of Caricom is a long awaited and most welcome development towards the harmonization of intellectual property laws in the region. Even more importantly, it is an indication that Caricom leadership has at long last, after a lengthy period of stagnation and indeterminacy, finally decided to engage the process of thought and action necessary for the promulgation of a legal and regulatory framework for Caribbean intellectual property. The convention is expected to be enacted later in 2017.
WIPO Report Recommends More “Cooperation” Under Patent Cooperation Treaty 03/02/2017 by Intellectual Property Watch 3 Comments As it published the three-millionth international patent application under its Patent Cooperation Treaty (PCT) on 2 February, the World Intellectual Property Office suggested that there may be ways to improve the system in the future.
Resolution On Compulsory Licences For Patented Medicines Passes In Chile 01/02/2017 by Kim Treanor for Intellectual Property Watch 1 Comment A resolution has been passed by Chile’s Chamber of Deputies, a branch of its National Congress, to encourage the use of compulsory licences to import generic versions of a patented drug when necessary to protect and promote the health of the population.